PWMAG
AGRX

Pinnacle Wealth Management Advisory Group’s Agile Therapeutics AGRX Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10
Closed -$50K – 205
2019
Q4 		$50K Buy
+10
New +$34.9K 0.02% 188
2017
Q2 		– Sell
-5
Closed -$32K – 140
2017
Q1 		$32K Hold
5
– – 0.02% 127
2016
Q4 		$57K Sell
5
-20
-80% -$280K 0.04% 122
2016
Q3 		$350K Sell
25
-13
-34% -$186K 0.27% 87
2016
Q2 		$572K Sell
38
-1
-3% -$13.7K 0.45% 64
2016
Q1 		$484K Buy
39
+15
+63% +$194K 0.43% 66
2015
Q4 		$471K Sell
24
-1
-4% -$15.8K 0.43% 67
2015
Q3 		$334K Hold
25
– – 0.32% 72
2015
Q2 		$426K Hold
25
– – 0.39% 69
2015
Q1 		$460K Buy
+25
New +$438K 0.41% 68

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's AGRX Position: Q1 2020 in Review

Pinnacle Wealth Management Advisory Group sold out of Agile Therapeutics (AGRX) in Q1 2020, closing a stake of 10 shares — an estimated $50K sold.

Pinnacle Wealth Management Advisory Group first reported a position in AGRX in Q1 2015 and held it in 10 quarters. The position peaked at $572K in Q2 2016. 61 funds tracked by Wall St. Rank hold AGRX as of Q1 2020.

  • Pinnacle Wealth Management Advisory Group reported no remaining Agile Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Pinnacle Wealth Management Advisory Group sold 10 Agile Therapeutics shares in Q1 2020, an estimated $50K.
  • Pinnacle Wealth Management Advisory Group first reported a position in Agile Therapeutics in Q1 2015 and held it in 10 quarters.
  • Pinnacle Wealth Management Advisory Group's Agile Therapeutics position peaked at $572K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held Agile Therapeutics as of Q1 2020.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q1 2020, filed 8 May 2020.